Disease burden in a large cohort of asylum seekers and refugees in Germany.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
30 Jan 2021
Historique:
entrez: 1 3 2021
pubmed: 2 3 2021
medline: 19 8 2021
Statut: epublish

Résumé

Currently, health care systems worldwide are challenged with providing care to an increasing number of migrants, refugees, and displaced persons. In this article, we report on disease burden and drug prescription patterns in a large refugee cohort in Germany. We conducted a cross-sectional study of anonymized medical records including demographic data, diagnoses, and drug prescriptions in two refugee reception centres between 2015 and 2019. Refugees and migrants received medical assistance exclusively through the on-site clinics. Thus, this study represents all medical visits of the housed residents. In total, n = 15531 diagnoses from n = 4858 patients in a cohort of n = 10431 accommodated refugees were recorded. N = 11898 medications were prescribed. Overall, 29.8% of all refugees sought medical attention. Half of the patients were female (49.6%), the average age was 23.8 years (SD [standard deviation] 17.0, min 0, max 81), and 41.5% were minors (<18 years). Most patients had Middle Eastern or Northern African origin (63.9%). The largest proportion of diagnoses belonged to the ICD (International Statistical Classification of Diseases and Related Health Problems) category "R" (miscellaneous, 33.5%), followed by diseases of the respiratory system (category "J", 16.5%), or the musculoskeletal system (category "M", 7.1%). Non-steroidal anti-inflammatory drugs were most frequently prescribed. This analysis in two large refugee centres in Germany shows that about one third of refugees seek medical attention upon initial arrival. Complaints are manifold, with a high prevalence of respiratory infections.

Sections du résumé

BACKGROUND BACKGROUND
Currently, health care systems worldwide are challenged with providing care to an increasing number of migrants, refugees, and displaced persons. In this article, we report on disease burden and drug prescription patterns in a large refugee cohort in Germany.
METHODS METHODS
We conducted a cross-sectional study of anonymized medical records including demographic data, diagnoses, and drug prescriptions in two refugee reception centres between 2015 and 2019. Refugees and migrants received medical assistance exclusively through the on-site clinics. Thus, this study represents all medical visits of the housed residents.
RESULTS RESULTS
In total, n = 15531 diagnoses from n = 4858 patients in a cohort of n = 10431 accommodated refugees were recorded. N = 11898 medications were prescribed. Overall, 29.8% of all refugees sought medical attention. Half of the patients were female (49.6%), the average age was 23.8 years (SD [standard deviation] 17.0, min 0, max 81), and 41.5% were minors (<18 years). Most patients had Middle Eastern or Northern African origin (63.9%). The largest proportion of diagnoses belonged to the ICD (International Statistical Classification of Diseases and Related Health Problems) category "R" (miscellaneous, 33.5%), followed by diseases of the respiratory system (category "J", 16.5%), or the musculoskeletal system (category "M", 7.1%). Non-steroidal anti-inflammatory drugs were most frequently prescribed.
CONCLUSIONS CONCLUSIONS
This analysis in two large refugee centres in Germany shows that about one third of refugees seek medical attention upon initial arrival. Complaints are manifold, with a high prevalence of respiratory infections.

Identifiants

pubmed: 33643633
doi: 10.7189/jogh.11.04002
pii: jogh-11-04002
pmc: PMC7897448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04002

Informations de copyright

Copyright © 2021 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest: The authors completed the ICMJE Unified Competing Interest form at (available upon request from the corresponding author), and declare no conflicts of interest.

Références

Lancet. 2016 Aug 13;388(10045):646-8
pubmed: 27533428
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Dtsch Med Wochenschr. 2016 Jan;141(1):e8-15
pubmed: 26710209
J Psychosom Res. 2013 Jan;74(1):82-5
pubmed: 23272993
Int J Environ Res Public Health. 2017 Jun 07;14(6):
pubmed: 28590438
Antimicrob Resist Infect Control. 2018 Sep 20;7:113
pubmed: 30250735
Euro Surveill. 2018 Mar;23(10):
pubmed: 29536830
Int J Environ Res Public Health. 2019 Nov 11;16(22):
pubmed: 31718046
Epidemiol Psychiatr Sci. 2019 Jul 31;29:e40
pubmed: 31364579
BMJ Open. 2017 Aug 4;7(8):e015981
pubmed: 28780549
Vaccine. 2018 Mar 14;36(12):1664-1672
pubmed: 29454516
Health Policy. 2019 Sep;123(9):845-850
pubmed: 31326127
BMC Infect Dis. 2012 Jan 17;12:7
pubmed: 22251705
Infection. 2016 Dec;44(6):781-787
pubmed: 27449329
BMC Fam Pract. 2018 May 16;19(1):64
pubmed: 29769017
Confl Health. 2019 Aug 20;13:39
pubmed: 31452677
BMJ Open. 2016 Nov 24;6(11):e013963
pubmed: 27884856
Int J Environ Res Public Health. 2018 Jun 14;15(6):
pubmed: 29904012
Int J Environ Res Public Health. 2020 Sep 18;17(18):
pubmed: 32962038
Lancet. 2015 Mar 14;385(9972):931-4
pubmed: 25784334
Am J Ind Med. 2010 Apr;53(4):329-37
pubmed: 20196095
Health Commun. 2020 Mar 25;:1-14
pubmed: 32212869
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Apr;60(4):462-470
pubmed: 28229173
ERJ Open Res. 2019 Dec 08;5(4):
pubmed: 31832428
J Clin Pharm Ther. 2006 Aug;31(4):309-19
pubmed: 16882099
Int J Environ Res Public Health. 2019 Jan 16;16(2):
pubmed: 30654588
Euro Surveill. 2017 Mar 23;22(12):
pubmed: 28367795
BMC Public Health. 2020 Feb 7;20(1):200
pubmed: 32033555
Lancet. 2020 Apr 4;395(10230):1090
pubmed: 32247379
Lancet Infect Dis. 2016 Aug;16(8):e173-7
pubmed: 27339456
Eur J Public Health. 2009 Jan;19(1):59-64
pubmed: 19158102
Psychother Psychosom Med Psychol. 2017 Apr;67(3-04):119-125
pubmed: 27750355
BMC Int Health Hum Rights. 2019 Jun 13;19(1):20
pubmed: 31196192
BMC Int Health Hum Rights. 2018 Feb 8;18(1):11
pubmed: 29422090
Int J Environ Res Public Health. 2018 Oct 01;15(10):
pubmed: 30275412
Public Health. 2017 Dec;153:1-8
pubmed: 28800522
PLoS One. 2015 Jul 22;10(7):e0131483
pubmed: 26201017
Int J Environ Res Public Health. 2018 Sep 05;15(9):
pubmed: 30189649
J Public Health (Oxf). 2016 Jun;38(2):212-22
pubmed: 25922367
Confl Health. 2018 Jan 29;12:3
pubmed: 29422945
Public Health Rev. 2019 Mar 19;40:3
pubmed: 30923641
JAMA. 2005 Aug 3;294(5):602-12
pubmed: 16077055
Glob Public Health. 2020 Dec;15(12):1871-1877
pubmed: 32507050
Psychother Psychosom Med Psychol. 2018 Jan;68(1):22-29
pubmed: 28470633

Auteurs

Frank Müller (F)

Department of General Practice, University Medical Centre Goettingen, Goettingen, Germany.

Evelyn Kleinert (E)

Department of General Practice, University Medical Centre Goettingen, Goettingen, Germany.

Nele Hillermann (N)

Department of General Practice, University Medical Centre Goettingen, Goettingen, Germany.

Anne Simmenroth (A)

Department of General Practice, University Medical Centre Goettingen, Goettingen, Germany.
Department of General Practice, University Medical Centre Wuerzburg, Wuerzburg, Germany.

Eva Hummers (E)

Department of General Practice, University Medical Centre Goettingen, Goettingen, Germany.

Anna Zychlinsky Scharff (AZ)

Department for Pediatrics, Hannover Medical School, Hannover, Germany.

Christian Dopfer (C)

Department of Paediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, Hannover, Germany.

Christine Happle (C)

Department of Paediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, Hannover, Germany.
German Centre for Lung Research, Biomedical Research in End Stage and Obstructive Lung Disease/ BREATH, Hannover, Germany.

Alexandra Jablonka (A)

German Centre for Infection Research (DZIF), Partner Site Hannover-Brunswick, Braunschweig, Germany.
Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH